Here, we inhibited MYC in CCA cells (KKU-M213 and RBE) using a small-molecule inhibitor before subjecting them to CAR-T cells to assess any cytotoxic effect the inhibitor may have on the cancer cells itself, and to determine non-lethal concentration ranges. The gene discussed is MYC; the disease is cholangiocarcinoma.